Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer
- 1 January 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 41 (S2) , 103-108
- https://doi.org/10.1002/ijc.2910410724
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Demonstration of the hepatic uptake of radiolabelled immunotoxins using gamma scintigraphyEuropean Journal of Cancer and Clinical Oncology, 1987
- Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograftCancer Immunology, Immunotherapy, 1986
- Study of the plasma clearance of antibody – ricin‐A‐chain immunotoxinsEuropean Journal of Biochemistry, 1986
- Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36)Nuclear Medicine Communications, 1985
- Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigenBritish Journal of Cancer, 1984
- The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumoursBritish Journal of Surgery, 1984
- Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancerBritish Journal of Cancer, 1983
- Preparation of 125iodine-labelled methotrexate and its use in a magnetisable particle solid-phase radioimmunoassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Development and application of a radioimmunoassay for methotrexateBritish Journal of Cancer, 1977